Introduction
Tricuspid valve replacement (TVR) secondary to infective endocarditis (IE) is challenging with high rates of complications and mortality. Intravenous drug use (IVDU), instrumentation such as peripherally inserted central catheter, and long-term central venous catheter lines are pre-disposing factors for right sided endocarditis. Common sites of embolization include the pulmonary system causing either an infection or a clot. In the setting of an inter-atrial shunt, embolic strokes
Learning points
• Surgical options for tricuspid valve replacement (TVR) with extracellular-based material have shown promising outcomes with little reported data of long-term complications.
• Surveillance blood cultures should be obtained in high-risk patients and rapid surgical intervention, involving a multi-disciplinary team should be considered despite sepsis. long-term data is lacking. To the best of our knowledge, this is the first reported case of an infected CorMatrix TV that embolized to the pulmonary artery (PA).
Timeline Case presentation
A 27-year-old Caucasian woman with hepatitis C (HCV), current IVDU, and TVR was transferred to our institution for IE due to surveillance blood cultures yielding Candida parapsilosis and Staphylococcus. Three months prior to this admission, she had completed a 6-week course of antibiotics, followed by TVR with a CorMatrix valve for endocarditis. Switched amphotericin B to micafungin and continued on amikacin, imipenem, and azithromycin. Recommendations were to complete micafungin for a total of 6 weeks and antibiotics for a total of 3 months /L (normal range 150 000-450 000 Â 10 9 /L), normocytic anaemia with haemoglobin of 9.7 g/dL (normal range 12-16 g/dL), and an international normalized ratio (INR) >10 (normal rage of 1.0-2.0) reversed with IV vitamin K and discontinuation of coumadin. Erythrocyte sedimentation rate (ESR) was 27 mm/h (normal range 0-23 mm/h), fibrinogen was 140 mg/dL (normal range 200-400 mg/dL). Aspartate transaminase (AST) was 55 U/L and ALT -alanine transaminase was 20 U/L (normal range are 10-31 U/L and 10-41 U/L, respectively). Peripheral blood smear revealed numerous schistocytes and rare large platelets. Transthoracic echocardiogram (TTE) showed a mobile mass involving the TV with a large pericardial effusion measuring 4.21 cm by 3.73 cm. There was also evidence of elevated intrapericardial pressure causing diastolic compression of the right ventricle (RV) ( Figure 1A , Supplementary material online, Videos S1A, B, S2A, B, S3A, B). Removal of 600 mL of serous pericardial fluid returned negative for bacteria, fungi, and viruses. Analysis was consistent with an exudative effusion. There was no apparent abscess or paravalvular leak. Repeat TTE following pericardiocentesis showed reduced pericardial effusion with relief of RV compression. On Day 8, she developed cardiogenic shock with worsening metabolic acidosis despite vasopressors that were started the day before. TTE showed torrential tricuspid regurgitation (TR) with a filling defect in the right PA ( Figure  1B , Supplementary material online, Video S4A, B). Left ventricular function was normal but the RV was dilated and poorly functional. There was an attempt to perform CT chest, however, due to haemodynamic instability, she underwent emergent surgery. Several units of platelets, fresh frozen plasma, and packed red blood cells were required during surgery. The TV was replaced using a Biocor valve ( Figure 1C , Supplementary material online, Video S5) following retrieval of the CorMatrix valve from the PA. Pathology of the extracted valve showed acutely inflamed tissue with bacteria, fungal element and acid-fast bacilli. She was discharged home on a prolonged course of antibiotics with Linezolid, Amikacin and Micafungin. All her laboratory values improved. Upon discharge, the patient moved out of state, however, was re-admitted within 2 months for blood cultures positive for AFB. TEE revealed new TV vegetations. Due to recurrent IVDU, she was not a candidate for surgical intervention and was treated with 6 weeks of Linezolid and Imipenem. The patient has since been lost to follow-up.
Discussion
This case presents several important points including the challenges of TVR, need for additional long-term data on ECM in endocarditis and multi-disciplinary management of recurrent IE in high-risk patients. The patient's presentation raised several differential diagnoses. Anasarca and JVD was thought to be due to portal hypertension from hepatic disease vs. right sided heart failure (HF). Liver disorder was unlikely as the CT of the abdomen did not reveal any portal vein thrombosis, cirrhosis, or oesophageal varices and HCV load was mildly elevated but not higher than previous levels. Her presentation was likely secondary to decreased RV function with TR seen on TTE. Thrombocytopenia was multifactorial from sepsisrelated disseminated intravascular coagulation and myelosuppression from antibiotic use. Due to creatinine levels being at baseline and normal neurological status, thrombotic thrombocytopenic purpura, and haemolytic uremic syndrome were unlikely. The presentation of acute right sided HF with anasarca, JVD, supratherapeutic INR, and thrombocytopenia was due to recurrent polymicrobial bacteraemia and IE, in the setting of a PE on coumadin.
TV endocarditis is a known complication of IVDU. Morbidity and mortality rates (1% to 6%) are higher in patients with replaced or repaired TV and recurrent endocarditis. 2, 3 The causative organism has a major role with Staphylococci carrying an increased mortality rate. 3 Management is multidisciplinary often involving cardiology, cardiothoracic surgery, infectious disease and in certain situations, critical care medicine. Early surgical intervention is indicated in haemodynamic instability, septic embolism, uncontrolled infection and IE caused by Staphylococci, fungi, Coxiella, and Chlamydia. 4 Early surgery results in lower rates of recurrence and nearly 90% chance of survival. 5 However, in the setting of active infection, surgery should be delayed due to higher operative complications. 2 Due to the unique anatomy of the TV and associated risks with bioprosthetic and mechanical valves, there are no ideal prostheses designed for replacement. 6 The fragility of the leaflet tissue and proximity of the right coronary artery to the TV and annulus renders the procedure particularly challenging. 7 In comparison, the mitral valve (MV) is anatomically closer to the left ventricular outflow tract and the aortic valve, which also causes limitations, but the durability of the MV annulus decreases the risk of complications. 8 Technology in both valvular procedures has advanced with the CorMatrix valve for the TV and the transcatheter approach for the MV. Multimodality imaging tools are often used to measure the annulus size in order to minimize complications. The successful management of TV endocarditis includes the excision of all infected tissue without valve replacement, but this is often complicated by the development of TR, which cannot be tolerated in up to 25% of patients. 9 In the absence of guidelines, the current best approach is monitoring high risk patients through blood culture surveillance. If there is concern for recurrent IVDU, it is reasonable to obtain blood cultures more frequently. The CorMatrix ECM derived from porcine small intestines functions as an acellular bioscaffold allowing for native integration of the valve and tissue regeneration. It has garnered increasing interest for use in valve replacement as it eliminates the need for chronic anticoagulation therapy and reduces the risk of valve calcification and recurrent infection. 10 In the adult population, the utility of ECM in valve 11, 12 however, long-term outcomes are lacking. CorMatrix ECM naturalization occurs via an inflammatory response leading to fibrin deposition, which is subsequently replaced by smooth muscle and endothelial cells. In our patient, inadequate timing for regeneration vs. intense inflammation in the setting of persistent infection, may have predisposed the valve to damage and dehiscence. Contrary to the manufacturer's claim, there are reports of adverse effects involving inflammation of the CorMatrix valve. Inflammation, fibrosis, neovascularization, and necrosis were observed in 12 explanted CorMatrix specimens with little to no evidence of remodelling 12 and in another study, no resemblance to the native valve at 9 months. 13 Among 44 patients who had MV repair using CorMatrix ECM, 32% had recurrence of severe mitral regurgitation as a result of patch failure. 14 It is therefore possible that inflammation may play a role in failure however, mechanisms still need to be further elucidated.
Conclusion
Given the risk for dire complications in delayed intervention, close monitoring of patients with IE after TVR is crucial, especially in ongoing IVDU. Despite promising results with CorMatrix valves, recurrent TV IE increases mortality and morbidity. Timing of surgical intervention should involve multidisciplinary evaluation and discussion, however, in the setting of cardiogenic shock, emergent TVR is necessary.
Supplementary material
Supplementary material is available at European Heart Journal -Case Reports online.
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